<DOC>
	<DOCNO>NCT01374854</DOCNO>
	<brief_summary>Umbilical mesenchymal stem cell ( UC-MSCs ) infusion suppose promising regeneration therapy mild side effect indicate large quantity animal experiment clinical trial . There UC-MSCs clinical trial regard diabetes mellitus . The investigator hypothesize infusion USC-MSCs may provide multiple signal beta-cell regeneration even re-differentiate local tissue diabetes mellitus patient , result improvement diabetic control , effect may promote concomitant infusion bone marrow mononuclear cell maximize intra-arterial pancreatic infusion angiography .</brief_summary>
	<brief_title>Umbilical Mesenchymal Stem Cells Mononuclear Cells Infusion Type 1 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Male female patient age 18 65 year age . Ability provide write informed consent . Mentally stable able comply procedure study protocol . Clinical history compatible type 1 diabetes ( T1DM ) define Expert Committee Diagnosis classification Diabetes Mellitus Onset T1DM disease ≤ 35 year age . T1DM duration ≥ 2 ≤ 20 year time enrollment . Basal Cpeptide ≤ 0.3 ng/mL HbA1c ≥ 7.5 time enrollment . BMI &gt; 35 kg/m^2 . Insulin requirement &gt; 100 U/day . Creactive protein ( hsCRP ) &gt; 3.00ng/ml Uncontrolled blood Pressure : SBP &gt; 160 mmHg DBP &gt; 100 mmHg time enrollment . Evidence renal dysfunction , serum creatinine &gt; 1.5 mg/dl ( male ) 1.4 mg/dl ( female ) . Proteinuria &gt; 300 mg/day Evidence cardiovascular disease , exist congestive cardiac failure physical exam and/or acute coronary syndrome past 6 month . For female participant : Positive pregnancy test , presently breastfeed , unwillingness use effective contraceptive measure duration study . For male participant : intent procreate 3 month intervention unwillingness use effective measure contraception . Oral contraceptive , Norplant® , DepoProvera® , barrier device spermicide acceptable contraceptive method ; condom use alone acceptable Active infection include hepatitis C , HIV , TB determine positive skin test clinical presentation , treatment suspect TB . Positive test acceptable associate history previous vaccination absence sign active infection . Positive test otherwise acceptable , even absence active infection time evaluation Known active alcohol substance abuse include cigarette/cigar smoking Baseline Hemoglobin low limit normal local laboratory ; lymphopenia ( &lt; 1,000/L ) , neutropenia ( &lt; 1,500/L ) , thrombocytopenia ( platelet &lt; 100,000/L ) . A history Factor V deficiency coagulopathy define INR &gt; 1.5 , PTT &gt; 40 , PT &gt; 15 . Any coagulopathy medical condition require longterm anticoagulant therapy ( e.g. , warfarin ) transplantation ( lowdose aspirin treatment allow ) patient INR &gt; 1.5 . Acute chronic pancreatitis . Symptomatic peptic ulcer disease . Hyperlipidemia despite medical therapy ( fast LDL cholesterol &gt; 130 mg/dl , treat untreated ; and/or fast triglyceride &gt; 200 mg/dl ) . Receiving treatment medical condition require chronic use systemic steroid . Symptomatic cholecystolithiasis . Use investigational agent within 4 week enrollment . Admission hospital reason 14 day prior enrollment ( sign consent ) . Presence active proliferative diabetic retinopathy macular edema Any malignancy Abnormal liver function &gt; 1.5 x ULN Abdominal aortic aneurysm History cerebrovascular accident Any patient acute subacute decompensation diabetes Any acute chronic infectious condition criterion investigator would risk patient . Subjects hypoproteinemia , cachexia terminal state Subjects history anorexia/bulimia Subjects respiratory insufficiency Any medical condition , opinion investigator , interfere safe completion trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>type 1 diabetes mellitus</keyword>
	<keyword>umbilical mesenchymal stem cell</keyword>
	<keyword>mononuclear cell</keyword>
</DOC>